This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Aerospace Dongfanghong Development Ltd, Sz Dji Technology Co., Ltd.. Active years: 2021-2023.
Location History:
- Guangdong, CN (2021)
- Shenzhen, CN (2023)
Company Filing History:
1 out of 1 
1 out of 1,264 
Years Active: 2021-2023
Title: Lijun Xue - Innovator in Cancer Treatment
Introduction
Lijun Xue is a notable inventor based in Changshu, China. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative treatments for cancer. Her work focuses on the creation of new crystalline forms of a KRAS G12C inhibitor compound, which holds promise for treating KRAS G12C-mutant cancers.
Latest Patent Applications
Lijun Xue's latest patent application is titled "NEW CRYSTALLINE FORMS OF A KRAS G12C INHIBITOR COMPOUND." This application provides details on the crystalline forms of the KRAS G12C inhibitor compound and the processes for their preparation. Additionally, it includes a pharmaceutical composition that comprises these crystalline forms along with at least one pharmaceutically acceptable excipient. This composition is intended for use as a medicament, specifically targeting cancer treatment.
Conclusion
Lijun Xue's innovative work in developing new pharmaceutical compositions showcases her commitment to advancing cancer treatment options. Her contributions are vital in the ongoing fight against cancer, particularly for patients with KRAS G12C mutations.